Skip to main content
OpenTrials
Completed

NCT Number: NCT04830956

Evaluation of Comfort in Subjects With Moderate Dry Eye Disease

The purpose of this study is to evaluate the comfort of an ocular lubricant in dry eye subjects. This study will be conducted in Canada and Australia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alcon Investigator 8169

Carlton, Victoria, 3053, Australia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Key Inclusion Criteria:

  • Able to understand and sign an information consent letter
  • Willing and able to follow instructions and maintain the appointment schedule
  • Has dry eye symptoms

Key Exclusion Criteria:

  • Has suffered any ocular injury to either eye in the past 12 weeks
  • Is pregnant or lactating at the time of enrollment

Other protocol-specified inclusion/exclusion criteria may apply.

Treatment and study plan

FID123238

Other

Lubricant applied to the ocular surface

Systane Hydration

Other

Drops applied to the ocular surface

Primary outcomes

  1. Change from baseline in comfort rating

    Time frame: Baseline, up to 12 Hours (Day 1, each product)

    A visual analogue scale will be used

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 5, 2021
Registry last updated
Nov 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.